ACROBiosystems

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems Group has established numerous long-term and stable partnerships with the worlds top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics....

Proprietary hek293 expression platform,in-house developed enzymatic and chemical biotin labeling technique,covid-19 antigens and antibodies,car-t,reagents for covid-19 vaccine development and evaluation,sars-cov-2 related kit products,targets for antibody-drug conjugates,hot target for bispecific antibody,cd3,bispecific antibody,sars-cov-2 mutants,adcs,sars-cov-2 kits,targets for car-t cell therapy,multi-pass transmembrane proteins and technology platforms,immune checkpoint,cytokine,bsab targets,fc receptors,mabsol biotinylated protein,enzymes,anti-idiotypic antibodies,cell gene therapy,and gmp grade cytokines

Acrobiosystems operates in the Biotechnology research industry.

Acrobiosystems's HQ phone number is +1 8008100816

Acrobiosystems's revenue is 11m - 100m

Acrobiosystems has 51 - 200 employees.